Precursor Condition
Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia
CI-CAN-00002584EINExplore in graph →
Precursor16 active trials
- NCIt
- C27789
Loading cancer entity…
Precursor Condition
CI-CAN-00002584EINExplore in graph →
Clinical trials
30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03300557 | Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Aug 29, 2025 | clinicaltrials |
| NCT06115577 | Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes | completed | — | 92 | Pirogov Russian National Research Medical UniversityOTHER | 0 |
| Nov 15, 2023 |
| clinicaltrials |
| NCT00483327 | Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate | completed | Phase 2 | 31 | NYU Langone HealthOTHER | 1 | Apr 4, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Aug 29, 2025source: clinicaltrials